The paper describes patient-reported outcomes, including glucose control, in patients with type 1 diabetes developing a COVID19 infection despite a full cycle of specific vaccination
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study) / Dicembrini, Ilaria; Scoccimarro, Daniele; Del Vescovo, Gloria Giovanna; Marinelli, Christian; Zago, Elena; Delli Poggi, Chiara; Pala, Laura; Mannucci, Edoardo. - In: DIABETES CARE. - ISSN 1935-5548. - ELETTRONICO. - 46:(2023), pp. e8-e9. [10.2337/dc22-0868]
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study)
Dicembrini, Ilaria;Scoccimarro, Daniele;Del Vescovo, Gloria Giovanna;Marinelli, Christian;Zago, Elena;Delli Poggi, Chiara;Pala, Laura;Mannucci, Edoardo
2023
Abstract
The paper describes patient-reported outcomes, including glucose control, in patients with type 1 diabetes developing a COVID19 infection despite a full cycle of specific vaccination
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
dc220868.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
499.24 kB
Formato
Adobe PDF
|
499.24 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
